Further, for lung squamous cell carcinomas, the survival prognosis was not statistically significant between low- and high-expression groups of GAPDHS (p = 0.094, Supplementary Figure 5a); and for lung adenocarcinomas, the survival prognosis was not statistically significant between low- and high-expression groups of GAPDHS (p = 0.39, Supplementary Figure 5a). This evidence concerns the gene GAPDHS and lung adenocarcinoma.